Interní Med. 2001; 3(8): 383-384

Skúsenosti s citalopramom v liečbe sprievodných depresívnych príznakov pri neurologických afekciách

prof. MUDr. Peter Kukumberg Ph.D, Ing. Ján Špánik
II. neurologická klinika LF UK FNsP akademika L. Dérera v Bratislave

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kukumberg P, Špánik J. Skúsenosti s citalopramom v liečbe sprievodných depresívnych príznakov pri neurologických afekciách. Interní Med. 2001;3(8):383-384.

V informatívne - orientačnej štúdii (dotazník) bol vyhodnotený efekt citalopramu po 8 týždňoch liečby u 245 pacientov s rôznymi neurologickými afekciami. Zistil sa výrazný ústup sprievodnej depresívnej symptomatiky (7 stupňová škála ,,Clinical Global Impression-). Práca sa venuje prínosu liečby citalopramom pri neurologických afekciách.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Andersen G: Post - stroke depression and pathological crying: clinical aspects and new pharmacological approaches. Aphasiology 1997, 11: 651-665. Go to original source...
    2. Gilman AG, Rall TW, Nies AS, Taylor P: The pharmacological basis of therapeutics, 9th edition. New York, Pergamon Pres 1996, s. 228.
    3. Mikulík R: Deprese u pacientů s cévními a mozkovými příhodami. Čes a slov Psychiat 2000, 96: 93-96.
    4. Pěničková V: Klinické zkušenosti s přípravkem citalopram (Seropram) v neurolodické ambulantní praxi. Neurologie pro praxi 2000, 1: 31-33.
    5. Stahl MS: Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Cambrige University Press 1999, s. 379.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.